The endobronchial valve is a one-way valve that is used in patients with chronic obstructive pulmonary disease (COPD). The endobronchial valve enables a unidirectional flow of air into the airways and thereby reduces shortness of breath in the case of lung diseases or emphysema. Emphysema is a precise type of the chronic obstructive pulmonary disease in which the alveoli are damaged. It is a form of chronic lung disease that causes shortness of breath.
Emphysema is also known as obstructive disorder, where the flow of air or exhalation slows or stops due to excessive inflammation of the alveoli. To treat emphysema, the endobronal valve closes during inhalation, preventing air from entering the damaged part of the lung. However, these valves open during the exhalation, letting out trapped air, which is proposed to reduce the pressure. The increasing popularity of the bronchoscopic lung volume reduction method for numerous lung-related diseases will bring immense growth prospects to the market for endobronchial valves during the evaluation period.
As per analysis, “Endobronchial Valve System Market: Current Analysis and Forecast (2021-2027)” the key companies operating in the global endobronchial valve system market include Novatech, Spiration Inc., Olympus Corporation, Pulmonx Corporation (ZEPHYR), Medlung and among others. Strategic partnerships are essential for the growth of the endobronchial valves market. Leading players are involved in these definite collaborations to reinforce their influence on the global endobronchial valve market.
Research & development activities constitute an important part of the endobronchial valve market. The players in the endobronchial valve market are investing heavily in these businesses. The activities help to formulate new business strategies and also lead to the emergence of new formulations which help to broaden the growth base of the Endobronchial Valves market. All of these factors translate into increased revenue, ultimately helping to lay a solid foundation for the growth of the Endobronchial Valves market.
By product type, endobronchial valve system market can be bifurcated as umbrella-shaped endobronchial valves and duckbill-shaped endobronchial valves. In addition, by end-user, market can be bifurcated as clinical research centers, hospitals, ambulatory surgery centers and others.
Major factor estimated to drive the growth of the endobronchial valve market is the increasing awareness of the bronchoscopic lung volume reduction procedure in various lung diseases. Consequently, rise in prevalence of smoking is likely to contribute the growth of the endobronchial valve market. Chronic obstructive pulmonary disease (COPD) is one of the main lung disorders. With the growth of the geriatric population, which is more often susceptible to lung disease, the demand for endobronchial valve is expected to increase at a linear rate.
Based on regional analysis, the North-America is a leading region in global endobronchial valve system market owing to rise in prevalence of chronic obstructive pulmonary disease across the region. The Europe and Asia-Pacific regions are estimated to witness higher growth rate growth in geriatric population over the forecast period. It is projected that future of the global endobronchial valve system market will be bright as a result of rise in awareness regarding the procedure for bronchoscopic lung volume reduction in a variety of lung-related diseases.
For More Information, refer to below link:-
Ankur Gupta, Head Marketing & Communications